Table 1.

Predictors of Treatment Dropout in Gender-Adjusted Multivariate Time to Event Analysis

Variable	Hazard Ratio	95% CI
MAT integrated with primary care	0.49	0.33-0.72
Buprenorphine maintenance dose
≥ 22 mg daily	0.53	0.30-0.95
16 to 20 mg daily	0.52	0.29-0.94
10 to 14 mg daily	0.95	0.51-1.79
Participation in any behavioral health	0.69	0.46-1.03
Having an active diagnosis of depression	0.63	0.42-0.93
Having an active diagnosis of attention deficit disorder	0.7	0.46-1.04
Unprescribed amphetamine/methamphetamine use during MAT	1.69	1.13-2.53
Cocaine use during MAT	1.39	0.93-2.07
History of intravenous drug use before MAT	1.65	1.04-2.61
History of heroin use before MAT	1.11	0.65-1.89